Literature DB >> 9419417

Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.

R Irby1, W Mao, D Coppola, R Jove, A Gamero, D Cuthbertson, D J Fujita, T J Yeatman.   

Abstract

Whereas genetic paradigms are now defined for the development of human colon cancer, little is known regarding the mechanisms that regulate development of the metastatic phenotype. Recent reports have indirectly linked the expression and activation of c-Src to the process of human colon cancer metastasis. Whereas v-Src, a highly activated mutational derivative of c-Src, has been shown to induce metastasis, normal c-Src has not been tested for this property. We hypothesized that c-Src overexpression in the milieu of a poorly metastatic cancer cell might permit the development of a highly metastatic cell. Two poorly metastatic human colon cancer cell lines were stably transfected with expression vectors encoding normal human c-Src. Clones producing 4-10-fold more c-Src than controls were injected s.c. and intrasplenically into the nude mouse to assess primary tumor growth and liver metastatic potential. Whereas metastatic potential was unaffected, primary tumor growth in vivo was significantly enhanced by c-Src overexpression. No effects on rates of tumor cell proliferation were seen in vitro. Our findings suggest that normal c-Src may be necessary but is insufficient for the induction of the metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9419417

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  12 in total

1.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 2.  Significance of talin in cancer progression and metastasis.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

Review 3.  The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.

Authors:  Christopher Lieu; Scott Kopetz
Journal:  Clin Colorectal Cancer       Date:  2010-04       Impact factor: 4.481

4.  Increases in c-Src expression level and activity do not promote the growth of human colorectal carcinoma cells in vitro and in vivo.

Authors:  Arkadiusz Welman; Christopher Cawthorne; Lourdes Ponce-Perez; Jane Barraclough; Sarah Danson; Stephen Murray; Jeff Cummings; Terry D Allen; Caroline Dive
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

5.  Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells.

Authors:  Jane Barraclough; Cassandra Hodgkinson; Alison Hogg; Caroline Dive; Arkadiusz Welman
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

6.  SRC is dephosphorylated at tyrosine 530 in human colon carcinomas.

Authors:  Shudong Zhu; Jeffrey D Bjorge; Donald J Fujita
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

7.  Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.

Authors:  E F Dunn; M Iida; R A Myers; D A Campbell; K A Hintz; E A Armstrong; C Li; D L Wheeler
Journal:  Oncogene       Date:  2010-10-18       Impact factor: 9.867

8.  Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway.

Authors:  Qian-Qian Zhang; Da-Lei Zhou; Yan Lei; Li Zheng; Sheng-Xia Chen; Hong-Ju Gou; Qu-Liang Gu; Xiao-Dong He; Tian Lan; Cui-Ling Qi; Jiang-Chao Li; Yan-Qing Ding; Liang Qiao; Li-Jing Wang
Journal:  Oncotarget       Date:  2015-02-20

9.  Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.

Authors:  C S Pichot; S M Hartig; L Xia; C Arvanitis; D Monisvais; F Y Lee; J A Frost; S J Corey
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

10.  Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue.

Authors:  Carole L C Poon; Anthony M Brumby; Helena E Richardson
Journal:  Int J Mol Sci       Date:  2018-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.